Foley Partner Paul Broude authored an article titled “The IPO Window Is Opening” in the March 2010 issue of MX: Medtech Executive. Broude examines the reasons for a device company to consider an initial public offering for its growth plans, stating that 2010 may bring the promise of IPOs for medical device companies to fund clinical trials, regulatory approvals, and the protection of the company’s intellectual property. He adds that going public enables some medical device and life science companies to continue growing while creating an exit vehicle for management and other shareholders.
Author(s)
Related Insights
August 1, 2025
Foley Ignite
Is an IPO Window Opening for H2 2025?
Executive Summary The IPO market is showing encouraging signs of recovery in 2025, with 201 companies going public year-to-date compared…
August 1, 2025
Foley Viewpoints
Maryland Insurance Administration Proposes to Revise Regulation Governing Disclosures of Credit Scoring Use in Private Passenger Automobile Insurance Rating
The Maryland Insurance Administration recently proposed to revise a regulation regarding the use and disclosure of credit history in underwriting and rate making for personal automobile policies.
July 31, 2025
Foley Viewpoints
Tsunamis and the National Flood Insurance Program
On July 30, an 8.8 magnitude earthquake occurred off of Russia’s Eastern Kamchatka coast, subsequently triggering tsunami warnings in, among other places, Japan and Hawaii.